Stockholm-based Agteria Biotech, a fast-growing agritech company, is expanding its presence in Umeå by moving into the laboratory facilities at Umeå Biotech Incubator (UBI). The company’s Research Technician, Madeleine Hollander, will be based on-site, providing Agteria with expanded research capacity.
“UBI’s lab capabilities will play a major role in our development,” says Madeleine Hollander.
Medicvent has secured two major hospital contracts in Sweden and France, with a combined value of approximately SEK 16 million. The awards follow a year of 11 percent revenue growth and mark an important step in the company’s international expansion.
“These contracts provide both an immediate financial contribution and highly valuable reference projects for our continued growth”, says Roger Folkhage, CEO of the Umeå-based company.
Construction of the facility in Umeå began in 2021. Diamyd Medical has now received GMP (Good Manufacturing Practice) certification and a manufacturing authorization from the Swedish Medical Products Agency for the production of biological investigational medicinal products.
“With this approval, the facility can play an important role for both Umeå and Sweden’s preparedness in a changing geopolitical landscape,” says Sofia Mayans, Head of Manufacturing Site in Umeå.
Umeå Biotech Incubator (UBI) has recruited Ololade Awoyomi to a new bridging role designed to accelerate the transition of life science projects from Umeå University’s Innovation Office into incubation at UBI.
Mucocort AB has received a patent in the United States for its innovative mucoadhesive patch technology, M045A, developed for the treatment of recurrent aphthous stomatitis (mouth ulcers). The approval marks a major milestone for the company and represents an important validation of its proprietary technology platform.
The Umeå Lab Fair sold out in record time this year. On May 7, 21 exhibiting companies will take part in Northern Sweden’s only dedicated life science lab fair.
“The strong interest is clear proof that we are meeting a real need, both among exhibitors and visitors,” says Christin Grundström, Lab and Community Manager at Umeå Biotech Incubator (UBI).
Umeå-based Nil Medical AB was awarded the Patient’s Award 2026 for its Nil Medical Vestpack at the MedTech4Health Innovation Award. The Patient’s Award recognizes the innovation judged to make the greatest difference for patients, users, and citizens.
Collaborations between academia and industry play an important role in turning research into practical applications. Researcher Chinmay Dwibedi shared insights from his work with BioGaia AB during the recent Open up for Innovation event at Umeå University.
SpinChem’s rotating bed reactor (RBR) technology is already deployed in more than 40 countries. Strengthened by the new EU–India Free Trade Agreement, the company is now expanding its presence in one of the world’s fastest-growing pharmaceutical markets through a partnership with Smart Labtech Private Ltd.
Umeå‑based Direkttest specializes in digital self‑sampling solutions, and continues its upward trajectory after its pandemic breakthrough. With a major new Swedish research contract secured and active discussions about expanding into the United Arab Emirates, the firm is now taking decisive steps toward both national and international growth.
The UBI company Nil Medical AB has been selected as a finalist in this year’s Medtech4Health Innovation Award for the Vestpack, a solution designed to make everyday life easier for children and young people undergoing medical treatment.
SpinChem AB has been certified according to ISO 9001:2015 by RISE, covering the company’s development, production, and delivery of rotating bed reactor (RBR) systems for advanced fluid processing.
Boreal Orchards is taking the next step in ecosystem restoration. With support from Vinnova (Sweden’s Innovation Agency) and industry partners, the company will develop methods to restore reindeer lichen in disturbed mining landscapes. The four-year project, ”symbios”, is funded with a total of SEK 15.5 million and brings together eight partners – including a Canadian mining company and the Swedish Sami Association.
Diamyd Medical has expanded its manufacturing strategy through a long‑term collaboration with APL in Umeå and a strategic partnership with NorthX Biologics, a contract development and manufacturing organisation (CDMO) based in Matfors, Sweden. Together, the parties will further develop and scale up production of the biological drug candidate retogatein (rhGAD65) in preparation for potential future commercialisation.
Umeå-based Nil Medical was one of eleven Nordic HealthTech companies chosen for the Propel International Boot Camp – an accelerator programme in the Yorkshire and Humber region of the United Kingdom. The boot camp was designed to provide a faster route into the UK market and offer expert support on the British healthcare system, legal frameworks, funding, networking and market growth.
METTLER TOLEDO has joined Umeå Biotech Incubutor (UBI) as a Lab Sponsor and has equipped the UBI laboratory with a RAININ SmartCheck.
Umeå Biotech Incubator växer nu med en ny Affärscoach för ett vikariat till och med 15 december 2026 – är du den?
Three researchers at Umeå University and one at the Swedish University of Agricultural Sciences (SLU) have been granted funding through Umeå Biotech Incubator’s (UBI) call “Pre‑Incubator Funding for Critical Experiments in Life Science.” The program targets researchers preparing to conduct decisive experiments that can validate or de‑risk early-stage innovation projects.
Mucocort AB today announced that the company has received a notice of approval for a Swedish patent covering the antimicrobial mechanism of action in its innovative treatment patch, M045A, developed for the treatment of oral ulcers caused by aphthae (Recurrent Aphthous Stomatitis).
It began as a spin-off from Umeå University. Ten years later, Prediktera is a global player in hyperspectral image analysis – and is now celebrating its 10th anniversary.